These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30145005)

  • 1. Discovery of novel spiro[chromane-2,4'-piperidine] derivatives as potent and orally bioavailable G-protein-coupled receptor 119 agonists.
    Koshizawa T; Morimoto T; Watanabe G; Fukuda T; Yamasaki N; Hagita S; Sawada Y; Okuda A; Shibuya K; Ohgiya T
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3236-3241. PubMed ID: 30145005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a novel series of potent and orally bioavailable GPR119 agonists.
    Koshizawa T; Morimoto T; Watanabe G; Watanabe T; Yamasaki N; Sawada Y; Fukuda T; Okuda A; Shibuya K; Ohgiya T
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3249-3253. PubMed ID: 28648463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
    Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brief overview on recent advances in spiro[chromane-2,4'-piperidine]-4(3H)-one-functionalized compounds in medicinal chemistry research.
    Ghatpande NG; Jadhav JS; Kaproormath RV; Soliman ME; Shaikh MM
    Bioorg Med Chem; 2020 Dec; 28(23):115813. PubMed ID: 33069128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives.
    Kubo O; Takami K; Kamaura M; Watanabe K; Miyashita H; Abe S; Matsuda K; Tsujihata Y; Odani T; Iwasaki S; Kitazaki T; Murata T; Sato K
    Bioorg Med Chem; 2021 Jul; 41():116208. PubMed ID: 34010766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
    Li Z; Pan M; Su X; Dai Y; Fu M; Cai X; Shi W; Huang W; Qian H
    Bioorg Med Chem; 2016 May; 24(9):1981-7. PubMed ID: 27020683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel pyrimido[5,4-d]pyrimidine derivatives as GPR119 agonist for treatment of type 2 diabetes.
    Fang Y; Xu J; Li Z; Yang Z; Xiong L; Jin Y; Wang Q; Xie S; Zhu W; Chang S
    Bioorg Med Chem; 2018 Aug; 26(14):4080-4087. PubMed ID: 30100020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the oxazabicyclo[3.3.1]nonane derivatives as potent and orally active GPR119 agonists.
    Dai X; Stamford A; Liu H; Neustadt B; Hao J; Kowalski T; Hawes B; Xu X; Baker H; O'Neill K; Woods M; Tang H; Greenlee W
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5291-4. PubMed ID: 26433449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel and potent GPR119 agonists with a spirocyclic structure.
    Harada K; Mizukami J; Kadowaki S; Matsuda I; Watanabe T; Oe Y; Kodama Y; Aoki K; Suwa K; Fukuda S; Yata S; Inaba T
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1228-1233. PubMed ID: 29519733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY; Kim YS; Kim CH; Choi HS; Yang J; Park SH; Kim DH; Rhee JK
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.
    Katamreddy SR; Carpenter AJ; Ammala CE; Boros EE; Brashear RL; Briscoe CP; Bullard SR; Caldwell RD; Conlee CR; Croom DK; Hart SM; Heyer DO; Johnson PR; Kashatus JA; Minick DJ; Peckham GE; Ross SA; Roller SG; Samano VA; Sauls HR; Tadepalli SM; Thompson JB; Xu Y; Way JM
    J Med Chem; 2012 Dec; 55(24):10972-94. PubMed ID: 23214471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a novel series of orally active, selective somatostatin receptor 2 agonists for the treatment of type 2 diabetes.
    Banno Y; Sasaki S; Kamata M; Kunitomo J; Miyamoto Y; Abe H; Taya N; Oi S; Watanabe M; Urushibara T; Hazama M; Niwa SI; Miyamoto S; Horinouchi A; Kuroshima KI; Amano N; Matsumoto SI; Matsunaga S
    Bioorg Med Chem; 2017 Nov; 25(21):5995-6006. PubMed ID: 28988629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
    Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists.
    Ye XY; Morales CL; Wang Y; Rossi KA; Malmstrom SE; Abousleiman M; Sereda L; Apedo A; Robl JA; Miller KJ; Krupinski J; Wacker DA
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2539-45. PubMed ID: 24755425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of novel 7-azaspiro[3.5]nonane derivatives as GPR119 agonists.
    Matsuda D; Kawamura M; Kobashi Y; Shiozawa F; Suga Y; Fusegi K; Nishimoto S; Kimura K; Miyoshi M; Takayama N; Kakinuma H; Ohtake N
    Bioorg Med Chem; 2018 May; 26(8):1832-1847. PubMed ID: 29486951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiro[chromane-2,4'-piperidine]-based histone deacetylase inhibitors with improved in vivo activity.
    Thaler F; Varasi M; Carenzi G; Colombo A; Abate A; Bigogno C; Boggio R; Carrara S; Cataudella T; Dal Zuffo R; Reali V; Vultaggio S; Dondio G; Gagliardi S; Minucci S; Mercurio C
    ChemMedChem; 2012 Apr; 7(4):709-21. PubMed ID: 22354629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification of orally bioavailable thrombopoietin agonists.
    Munchhof MJ; Antipas AS; Blumberg LC; Brissette WH; Brown MF; Casavant JM; Doty JL; Driscoll J; Harris TM; Wolf-Gouveia LA; Jones CS; Li Q; Linde RG; Lira PD; Marfat A; McElroy E; Mitton-Fry M; McCurdy SP; Reiter LA; Ripp SL; Shavnya A; Thomasco LM; Trevena KA
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1428-30. PubMed ID: 19186055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
    Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H
    Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-pot synthesis of novel tert-butyl-4-substituted phenyl-1H-1,2,3-triazolo piperazine/piperidine carboxylates, potential GPR119 agonists.
    Bashetti N; Shanmukha Kumar JV; Seelam NV; Prasanna B; Mintz A; Damuka N; Devanathan S; Solingapuram Sai KK
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126707. PubMed ID: 31630858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.